Association Between the Use of Antibiotics, Antivirals, and Hospitalizations Among Patients With Laboratory-confirmed Influenza

被引:7
|
作者
Sutton, S. Scott [1 ]
Magagnoli, Joseph [1 ]
Cummings, Tammy [2 ]
Hardin, James [3 ]
机构
[1] Univ South Carolina, Coll Pharm, Dept Clin Pharm & Outcomes Sci, 715 Sumter St 311D, Columbia, SC 29208 USA
[2] Wm Jennings Bryan Dorn Vet Affairs Med Ctr, Columbia, SC USA
[3] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC USA
关键词
influenza; hospitalization; antibiotic; antiviral; PANDEMIC INFLUENZA; BACTERIAL COINFECTION; VIRUS; MORTALITY; CARE; AZITHROMYCIN; OSELTAMIVIR; PNEUMONIA; ILLNESS; IMPACT;
D O I
10.1093/cid/ciaa074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Clinicians may prescribe antibiotics to influenza patients at high risk for bacterial complications. We explored the association between antibiotics, antivirals, and hospitalization among people with influenza. Methods. A retrospective cohort study of patients with confirmed influenza with encounters during January 2011-January 2019 was conducted using data from the Veterans Affairs Informatics and Computing Infrastructure (VINCI). We compared inpatient hospitalizations (all-cause and respiratory) within 30 days of influenza diagnosis between 4 patient cohorts: (1) no treatment (n = 4228); (2) antibiotic only (n = 671); (3) antiviral only (n = 6492); and (4) antibiotic plus antiviral (n = 1415). We estimated relative risk for hospitalization using Poisson generalized linear model and robust standard errors. Results. Among 12 806 influenza cases, most were white men (mean age, 57-60 years). Those with antivirals only, antibiotic plus antiviral, and antibiotics only all had a statistically significant lower risk of all-cause and respiratory hospitalization compared to those without treatment. Comparing the antibiotic plus antiviral cohort to those who were prescribed an antiviral alone, there was a 47% lower risk for respiratory hospitalization (relative risk, 0.53 [95% confidence interval, .31-.94]), and no other statistical differences were detected. Conclusions. Those prescribed an antiviral, antibiotic, or both had a lower risk of hospitalization within 30 days compared to those without therapy. Furthermore, intervention with both an antibiotic and antiviral had a lower risk of respiratory hospitalization within 30 days compared to those with an antiviral alone. Importantly, the absolute magnitude of decreased risk with antibiotic plus antiviral therapy is small and must be interpreted within the context of the overall risk of antibiotic usage.
引用
收藏
页码:566 / 573
页数:8
相关论文
共 50 条
  • [11] Optimizing Use of Antibiotics and Antivirals in Ambulatory Patients With Influenza
    Ison, Michael G.
    Linder, Jeffrey A.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (04) : 574 - 575
  • [12] Statins and outcomes of hospitalized patients with laboratory-confirmed 2017-2018 influenza
    Atamna, Alaa
    Babitch, Tanya
    Bracha, Mayaan
    Sorek, Nadav
    Haim, Ben-Zvi
    Elis, Avishay
    Bishara, Jihad
    Avni, Tomer
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (12) : 2341 - 2348
  • [13] Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019
    Tenforde, Mark W.
    Cummings, Charisse N.
    O'Halloran, Alissa C.
    Rothrock, Gretchen
    Kirley, Pam Daily
    Alden, Nisha B.
    Meek, James
    Yousey-Hindes, Kimberly
    Openo, Kyle P.
    Anderson, Evan J.
    Monroe, Maya L.
    Kim, Sue
    Nunez, Val Tellez
    McMahon, Melissa
    McMullen, Chelsea
    Khanlian, Sarah A.
    Spina, Nancy L.
    Muse, Alison
    Gaitan, Maria A.
    Felsen, Christina B.
    Lung, Krista
    Shiltz, Eli
    Sutton, Melissa
    Thomas, Ann
    Talbot, H. Keipp
    Schaffner, William
    Price, Andrea
    Chatelain, Ryan
    Reed, Carrie
    Garg, Shikha
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (01):
  • [14] Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza
    Coleman, Laura A.
    Waring, Stephen C.
    Irving, Stephanie A.
    Vandermause, Mary
    Shay, David K.
    Belongia, Edward A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (02) : 160 - 167
  • [15] Nasal colonization with Streptococcus pneumoniae and Staphylococcus aureus among hospitalized patients with laboratory-confirmed influenza
    Campigotto, Aaron
    Simor, Andrew E.
    McGeer, Allison
    Kiss, Alexander
    Mubareka, Samira
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (02) : 133 - 135
  • [16] The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza
    Papenburg, J.
    Charland, K. M.
    De Serres, G.
    Buckeridge, D. L.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (08) : 1592 - 1600
  • [17] Epidemiology and Clinical Outcomes of Hospitalizations for Acute Respiratory or Febrile Illness and Laboratory-Confirmed Influenza Among Pregnant Women During Six Influenza Seasons, 2010-2016
    Dawood, Fatimah S.
    Garg, Shikha
    Fink, Rebecca V.
    Russell, Margaret L.
    Regan, Annette K.
    Katz, Mark A.
    Booth, Stephanie
    Chung, Hannah
    Klein, Nicola P.
    Kwong, Jeffrey C.
    Levy, Avram
    Naleway, Allison
    Riesel, Dan
    Thompson, Mark G.
    Wyant, Brandy E.
    Fell, Deshayne B.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (10) : 1703 - 1712
  • [18] Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study
    Antoon, James W.
    Amarin, Justin Z.
    Hamdan, Olla
    Stopczynski, Tess
    Stewart, Laura S.
    Michaels, Marian G.
    Williams, John, V
    Klein, Eileen J.
    Englund, Janet A.
    Weinberg, Geoffrey A.
    Szilagyi, Peter G.
    Schuster, Jennifer E.
    Selvarangan, Rangaraj
    Harrison, Christopher J.
    Boom, Julie A.
    Sahni, Leila C.
    Munoz, Flor M.
    Staat, Mary Allen
    Schlaudecker, Elizabeth P.
    Chappell, James D.
    Clopper, Benjamin R.
    Moline, Heidi L.
    Campbell, Angela P.
    Spieker, Andrew J.
    Olson, Samantha M.
    Halasa, Natasha B.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [19] Statins and outcomes of hospitalized patients with laboratory-confirmed 2017–2018 influenza
    Alaa Atamna
    Tanya Babitch
    Mayaan Bracha
    Nadav Sorek
    Ben-Zvi Haim
    Avishay Elis
    Jihad Bishara
    Tomer Avni
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2341 - 2348
  • [20] Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018
    McLean, Huong Q.
    Hanson, Kayla E.
    Foster, Allison D.
    Olson, Scott C.
    Kemble, Sarah K.
    Belongia, Edward A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2020, 14 (02) : 173 - 181